$NXPT
Nexpoint Capital Inc

2023 Q3 Form 10-Q Financial Statement

#000119312523276929 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2022 Q3
Revenue $681.6K $555.6K
YoY Change 22.68% -34.4%
Cost Of Revenue $270.6K
YoY Change
Gross Profit $788.2K
YoY Change
Gross Profit Margin 115.63%
Selling, General & Admin $81.06K
YoY Change
% of Gross Profit 10.28%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $473.8K $562.7K
YoY Change -15.79%
Operating Profit $314.4K
YoY Change
Interest Expense $22.83K
YoY Change
% of Operating Profit 7.26%
Other Income/Expense, Net $25.48K $36.08K
YoY Change -29.38%
Pretax Income $704.5K
YoY Change
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $704.5K -$2.653M
YoY Change -126.56%
Net Earnings / Revenue 103.35% -477.43%
Basic Earnings Per Share $0.07 $0.27
Diluted Earnings Per Share $0.07 $0.27
COMMON SHARES
Basic Shares Outstanding 9.471M 9.882M
Diluted Shares Outstanding 9.471M 9.882M

Balance Sheet

Concept 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.351M
YoY Change
Cash & Equivalents $2.351M $2.174M
Short-Term Investments
Other Short-Term Assets $8.280K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $3.318M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $16.63K
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $47.60M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $3.318M
Total Long-Term Assets $47.60M
Total Assets $50.92M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $193.3K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.872M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.872M
Total Long-Term Liabilities $0.00
Total Liabilities $1.872M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$36.20M
YoY Change
Common Stock $9.356K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $49.05M
YoY Change
Total Liabilities & Shareholders Equity $50.92M
YoY Change

Cashflow Statement

Concept 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income $704.5K -$2.653M
YoY Change -126.56%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $5.007M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.287M
YoY Change
NET CHANGE
Cash From Operating Activities 5.007M
Cash From Investing Activities
Cash From Financing Activities -4.287M
Net Change In Cash 720.9K
YoY Change
FREE CASH FLOW
Cash From Operating Activities $5.007M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
NexPoint Capital, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
38-3926499
dei Entity Address Address Line1
EntityAddressAddressLine1
300 Crescent Court, Suite 700
dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001588272
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
814-01074
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75201
dei Local Phone Number
LocalPhoneNumber
972
dei City Area Code
CityAreaCode
628-4100
dei Security12g Title
Security12gTitle
Common Stock, par value $0.001 per share
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9356005
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2350754
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1629846
CY2023Q3 us-gaap Securities Purchased Under Agreements To Resell
SecuritiesPurchasedUnderAgreementsToResell
674077
CY2022Q4 us-gaap Securities Purchased Under Agreements To Resell
SecuritiesPurchasedUnderAgreementsToResell
0
CY2023Q3 cik0001588272 Dividends And Interest Receivable
DividendsAndInterestReceivable
188284
CY2022Q4 cik0001588272 Dividends And Interest Receivable
DividendsAndInterestReceivable
220194
CY2023Q3 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
8277
CY2022Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
15905
CY2023Q3 us-gaap Assets
Assets
50920633
CY2022Q4 us-gaap Assets
Assets
55251876
CY2023Q3 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
582500
CY2022Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
0
CY2023Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
193298
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
371736
CY2023Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
842040
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
870980
CY2023Q3 us-gaap Liabilities
Liabilities
1872403
CY2022Q4 us-gaap Liabilities
Liabilities
1557709
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9356005
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9356005
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9677593
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9677593
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
9356
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
9678
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
85241488
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
86949376
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36202614
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33264887
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
49048230
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
53694167
CY2023Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
5.24
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
5.55
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
417056
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
548857
us-gaap Investment Income Interest
InvestmentIncomeInterest
1526335
us-gaap Investment Income Interest
InvestmentIncomeInterest
1597694
CY2023Q3 cik0001588272 Payment In Kind Interest Income
PaymentInKindInterestIncome
34282
CY2022Q3 cik0001588272 Payment In Kind Interest Income
PaymentInKindInterestIncome
29338
cik0001588272 Payment In Kind Interest Income
PaymentInKindInterestIncome
95492
cik0001588272 Payment In Kind Interest Income
PaymentInKindInterestIncome
164117
CY2023Q3 us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
1058773
CY2022Q3 us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
993592
us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
2792041
us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
3108098
CY2023Q3 us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
207269
CY2022Q3 us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
254995
us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
705652
us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
836626
CY2023Q3 cik0001588272 Custodian And Accounting Service Fees
CustodianAndAccountingServiceFees
77265
CY2022Q3 cik0001588272 Custodian And Accounting Service Fees
CustodianAndAccountingServiceFees
78412
cik0001588272 Custodian And Accounting Service Fees
CustodianAndAccountingServiceFees
231112
cik0001588272 Custodian And Accounting Service Fees
CustodianAndAccountingServiceFees
232701
CY2023Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
47312
CY2022Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
55480
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
146989
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
171815
CY2023Q3 us-gaap Investment Company Shareholder Service Fee Expense
InvestmentCompanyShareholderServiceFeeExpense
41561
CY2022Q3 us-gaap Investment Company Shareholder Service Fee Expense
InvestmentCompanyShareholderServiceFeeExpense
53802
us-gaap Investment Company Shareholder Service Fee Expense
InvestmentCompanyShareholderServiceFeeExpense
124138
us-gaap Investment Company Shareholder Service Fee Expense
InvestmentCompanyShareholderServiceFeeExpense
156065
CY2023Q3 cik0001588272 Audit And Tax Fees
AuditAndTaxFees
41176
CY2022Q3 cik0001588272 Audit And Tax Fees
AuditAndTaxFees
44074
cik0001588272 Audit And Tax Fees
AuditAndTaxFees
123032
cik0001588272 Audit And Tax Fees
AuditAndTaxFees
123991
CY2023Q3 us-gaap Other Expenses
OtherExpenses
25480
CY2022Q3 us-gaap Other Expenses
OtherExpenses
36078
us-gaap Other Expenses
OtherExpenses
83365
us-gaap Other Expenses
OtherExpenses
69855
CY2023Q3 cik0001588272 Reports To Stockholders
ReportsToStockholders
25591
CY2022Q3 cik0001588272 Reports To Stockholders
ReportsToStockholders
21930
cik0001588272 Reports To Stockholders
ReportsToStockholders
63323
cik0001588272 Reports To Stockholders
ReportsToStockholders
60644
CY2023Q3 us-gaap Legal Fees
LegalFees
9631
CY2022Q3 us-gaap Legal Fees
LegalFees
13459
us-gaap Legal Fees
LegalFees
28527
us-gaap Legal Fees
LegalFees
53658
CY2023Q3 cik0001588272 Directors Fees
DirectorsFees
-1471
CY2022Q3 cik0001588272 Directors Fees
DirectorsFees
4421
cik0001588272 Directors Fees
DirectorsFees
9231
cik0001588272 Directors Fees
DirectorsFees
12134
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
473814
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
562651
us-gaap Operating Expenses
OperatingExpenses
1515369
us-gaap Operating Expenses
OperatingExpenses
1717489
CY2023Q3 cik0001588272 Expenses Waived Or Recouped By Adviser
ExpensesWaivedOrRecoupedByAdviser
96669
CY2022Q3 cik0001588272 Expenses Waived Or Recouped By Adviser
ExpensesWaivedOrRecoupedByAdviser
124667
cik0001588272 Expenses Waived Or Recouped By Adviser
ExpensesWaivedOrRecoupedByAdviser
280543
cik0001588272 Expenses Waived Or Recouped By Adviser
ExpensesWaivedOrRecoupedByAdviser
285378
CY2023Q3 cik0001588272 Operating Expenses Net
OperatingExpensesNet
377145
CY2022Q3 cik0001588272 Operating Expenses Net
OperatingExpensesNet
437984
cik0001588272 Operating Expenses Net
OperatingExpensesNet
1234826
cik0001588272 Operating Expenses Net
OperatingExpensesNet
1432111
CY2023Q3 us-gaap Net Investment Income
NetInvestmentIncome
681628
CY2022Q3 us-gaap Net Investment Income
NetInvestmentIncome
555608
us-gaap Net Investment Income
NetInvestmentIncome
1557215
us-gaap Net Investment Income
NetInvestmentIncome
1675987
CY2023Q3 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
22833
CY2022Q3 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-3208231
us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-1945508
us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-6111874
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
704461
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2652623
us-gaap Net Income Loss
NetIncomeLoss
-388293
us-gaap Net Income Loss
NetIncomeLoss
-4435887
CY2023Q3 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.07
CY2022Q3 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.06
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.16
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.17
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9471078
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9471078
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9882443
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9882443
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9580222
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9580222
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9940512
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9940512
CY2023Q2 us-gaap Assets Net
AssetsNet
49534811
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
681628
CY2023Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-242193
CY2023Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
265026
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
624915
CY2023Q3 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
275845
CY2023Q3 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
841972
CY2023Q3 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-486581
CY2023Q3 us-gaap Assets Net
AssetsNet
49048230
CY2023Q3 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.09
CY2022Q4 us-gaap Assets Net
AssetsNet
53694167
us-gaap Investment Income Net
InvestmentIncomeNet
1557215
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-4015983
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
2070475
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2558992
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
850782
us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
2549434
us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-4645937
CY2023Q3 us-gaap Assets Net
AssetsNet
49048230
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.27
CY2022Q2 us-gaap Assets Net
AssetsNet
58814472
CY2022Q3 us-gaap Investment Income Net
InvestmentIncomeNet
555608
CY2022Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
2056
CY2022Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-3210287
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1162960
CY2022Q3 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
298766
CY2022Q3 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
874461
CY2022Q3 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-4391278
CY2022Q3 us-gaap Assets Net
AssetsNet
54423194
CY2022Q3 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.09
CY2021Q4 us-gaap Assets Net
AssetsNet
62938908
us-gaap Investment Income Net
InvestmentIncomeNet
1675987
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
267485
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-6379359
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2331106
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
906130
us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
2654851
us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-8515714
CY2022Q3 us-gaap Assets Net
AssetsNet
54423194
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.27
us-gaap Profit Loss
ProfitLoss
-388293
us-gaap Profit Loss
ProfitLoss
-4435887
cik0001588272 Purchases Of Investment Securities
PurchasesOfInvestmentSecurities
-2582498
cik0001588272 Purchases Of Investment Securities
PurchasesOfInvestmentSecurities
-8148175
cik0001588272 Payment In Kind Investments
PaymentInKindInvestments
95492
cik0001588272 Payment In Kind Investments
PaymentInKindInvestments
164117
cik0001588272 Proceeds From Sales And Principal Repayments Of Investment Securities
ProceedsFromSalesAndPrincipalRepaymentsOfInvestmentSecurities
6617808
cik0001588272 Proceeds From Sales And Principal Repayments Of Investment Securities
ProceedsFromSalesAndPrincipalRepaymentsOfInvestmentSecurities
9358594
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-4015983
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
267485
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
2070475
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-6379359
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-194183
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-254765
cik0001588272 Increase Decrease In Receivable For Investments Sold
IncreaseDecreaseInReceivableForInvestmentsSold
-674077
cik0001588272 Increase Decrease In Receivable For Investments Sold
IncreaseDecreaseInReceivableForInvestmentsSold
990537
us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
-31910
us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
-160951
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
4453
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
29209
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-7628
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-5722
cik0001588272 Increase Decrease In Payable For Fund Shares Repurchased
IncreaseDecreaseInPayableForFundSharesRepurchased
0
cik0001588272 Increase Decrease In Payable For Fund Shares Repurchased
IncreaseDecreaseInPayableForFundSharesRepurchased
8389
cik0001588272 Increase Decrease In Payable For Investments Purchased
IncreaseDecreaseInPayableForInvestmentsPurchased
582500
cik0001588272 Increase Decrease In Payable For Investments Purchased
IncreaseDecreaseInPayableForInvestmentsPurchased
-301369
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-60428
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-68112
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-178438
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
229668
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5007492
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3464101
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2558992
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2331106
us-gaap Payments Of Dividends
PaymentsOfDividends
1727592
us-gaap Payments Of Dividends
PaymentsOfDividends
1770181
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4286584
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4101287
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
720908
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-637186
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1629846
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2811171
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2350754
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2173985
us-gaap Interest Paid Net
InterestPaidNet
95492
us-gaap Interest Paid Net
InterestPaidNet
164117
cik0001588272 Reinvestment Of Distributions Paid
ReinvestmentOfDistributionsPaid
850782
cik0001588272 Reinvestment Of Distributions Paid
ReinvestmentOfDistributionsPaid
906130
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
40578
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
36573
CY2023Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
0.10
CY2023Q3 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-09-20
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
2000000
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
2000000
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2000000
CY2023Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
3.75
CY2023Q3 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0537
CY2023Q3 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-02-27
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1457465
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1454526
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1424060
CY2023Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
7.50
CY2023Q3 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0549
CY2023Q3 us-gaap Investment Maturity Date
InvestmentMaturityDate
2027-09-30
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
658467
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
577634
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
524614
CY2023Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
0.15
CY2023Q3 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.02
CY2023Q3 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-04-07
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
3000000
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
2940261
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
3000000
CY2023Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
4
CY2023Q3 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0537
CY2023Q3 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-07-01
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
333333
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
333714
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
273333
CY2023Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
4
CY2023Q3 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0537
CY2023Q3 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-07-01
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1601236
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1603218
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1313013
CY2023Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
6.75
CY2023Q3 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0563
CY2023Q3 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-06-26
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1555556
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1495330
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
272222
CY2023Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
5.50
CY2023Q3 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0568
CY2023Q3 us-gaap Investment Maturity Date
InvestmentMaturityDate
2025-10-01
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
0
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
-1390
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
0
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
6807242
CY2023Q3 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.08
CY2023Q3 us-gaap Investment Maturity Date
InvestmentMaturityDate
2025-03-25
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
463314
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
463314
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
463314
CY2023Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
0.12
CY2023Q3 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.12
CY2023Q3 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-02-28
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
37563
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
37563
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
37405
CY2023Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
0.12
CY2023Q3 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.12
CY2023Q3 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-02-28
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
35047
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
35047
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
34900
CY2023Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
0.12
CY2023Q3 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.12
CY2023Q3 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-02-28
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
888109
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
888109
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
884379
CY2023Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
0.12
CY2023Q3 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.12
CY2023Q3 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-02-28
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
210254
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
210254
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
209371
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1166055
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
10436611
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
800
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
218666
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
16615
CY2023Q3 us-gaap Investment Maturity Date
InvestmentMaturityDate
2013-08-06
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
295435
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
169875
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
12
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
16627
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
16627
CY2023Q3 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-05-01
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
116808
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
313455
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
100836
CY2023Q3 us-gaap Investment Maturity Date
InvestmentMaturityDate
2027-05-01
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
214073
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
584792
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
154411
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
255247
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
255247
CY2023Q3 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
8500
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
17000
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
42500
CY2023Q3 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
16534
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1563928
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2199022
CY2023Q3 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
750000
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
2062500
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1732500
CY2023Q3 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
131670
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
2592506
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2154115
CY2023Q3 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
100000
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1500000
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2359000
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
4513115
CY2023Q3 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
23409
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
698189
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
753316
CY2023Q3 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
237
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
253404
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2346
CY2023Q3 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
14035
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1599990
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
4944671
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
14187470
CY2023Q3 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
1700
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1700000
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2885636
CY2023Q3 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
371112
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
371111
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
344513
CY2023Q3 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
737
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
8663085
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
7270216
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
7614729
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
10500365
us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.10
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
750
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
750000
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
684375
us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.07
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1000
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1000000
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
700000
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1384375
us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
135122
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1199993
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1467425
us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
72065
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
799994
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
830189
us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1863468
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
4080000
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
4581906
us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1311091
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
4000000
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
3699999
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
10579519
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
11963894
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
5738
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
16122
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
127670
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
11051
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
5175
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
104985
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
232655
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
2875
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
52988
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
9703
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
242358
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
46250353
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
47602572
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2097864
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-652206
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
49048230
CY2023Q3 cik0001588272 Percentage Of Qualifying Assets To The Total Assets
PercentageOfQualifyingAssetsToTheTotalAssets
0.70
CY2023Q3 cik0001588272 Percentage Of Non Qualifying Asset On Companys Total Asset
PercentageOfNonQualifyingAssetOnCompanysTotalAsset
0.049
CY2023Q3 us-gaap Equity Method Investments
EquityMethodInvestments
16627
CY2023Q3 cik0001588272 Percentage Of Net Assets Under Valuation Procedure
PercentageOfNetAssetsUnderValuationProcedure
0
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
3.75
CY2022Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0493
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-02-27
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1468909
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1465131
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1318346
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
6.75
CY2022Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.1218
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2027-09-30
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
668605
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
576001
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
511483
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.14
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-04-07
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
3000000
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
2926520
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
3000000
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
6.75
CY2022Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0374
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2028-11-06
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1500000
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1494084
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1422503
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.04
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-07-01
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
333333
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
333817
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
282500
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
4
CY2022Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0441
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-07-01
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1613305
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1615775
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1367276
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
3.75
CY2022Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0407
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2025-10-10
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
4518572
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
3709077
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1354645
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
4.50
CY2022Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0211
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2027-12-20
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1993177
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1963107
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1888535
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
6.75
CY2022Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0407
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-06-26
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1555556
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1481972
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1229869
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
5.50
CY2022Q4 us-gaap Investment Interest Rate Floor
InvestmentInterestRateFloor
0.0441
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2025-10-01
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
984615
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
980197
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
783793
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
13158950
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.11
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-02-28
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
32189
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
32189
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
32002
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.11
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-02-28
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
193108
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
193108
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
191988
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.11
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-02-28
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
815685
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
815684
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
810953
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.11
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
5114214
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-02-28
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
34500
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
34500
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
34300
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1069243
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
14228193
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
800
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
218666
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
7023
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
295435
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
169875
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
13
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
7036
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
7036
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.085
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-05-01
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
2728000
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
2460536
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2414839
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.06375
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2026-05-01
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
116808
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
313455
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
107648
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.08375
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2027-05-01
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
214073
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
584792
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
182430
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
290078
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2704917
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
8500
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
17000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
42500
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
11534
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
981428
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1591692
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
750000
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
2062500
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1732500
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
481670
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
9960591
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
7653730
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
100000
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1500000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2359000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
10012730
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
23409
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
698189
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1018779
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
237
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
253404
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2269
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
14035
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
19514684
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
2000
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
2000000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
3088750
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
451112
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1599990
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
451112
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
424468
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
100
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1215000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1176024
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1600492
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
4689242
CY2022 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.10
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
750
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
750000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
740625
CY2022 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.07
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1000
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1000000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
700000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1440625
CY2022 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
135122
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1199993
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1499989
CY2022 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
72065
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
799994
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
799994
CY2022 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1619048
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
4080000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
4549525
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1111111
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
4000000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
3677777
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
10527285
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
11967910
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2029-08-27
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
5738
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
16122
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
64553
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2029-08-27
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
11051
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
5175
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
96696
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
161249
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2039-05-01
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
2875
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
52987
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
20484
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
181733
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
54011971
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
53293715
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1420428
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-1019976
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
53694167
CY2022Q4 cik0001588272 Percentage Of Qualifying Assets To The Total Assets
PercentageOfQualifyingAssetsToTheTotalAssets
0.70
CY2022Q4 cik0001588272 Percentage Of Non Qualifying Asset On Companys Total Asset
PercentageOfNonQualifyingAssetOnCompanysTotalAsset
0.048
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
10000000
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2549002
CY2023Q3 us-gaap Assets
Assets
50920633
CY2023Q3 us-gaap Investment Sold Not Yet Purchased Percent Of Net Assets
InvestmentSoldNotYetPurchasedPercentOfNetAssets
0.25
CY2022Q4 us-gaap Investment Sold Not Yet Purchased Percent Of Net Assets
InvestmentSoldNotYetPurchasedPercentOfNetAssets
0.25
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates. </div>
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2350754
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1629846
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
252890
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
209418
CY2023Q3 us-gaap Financial Instruments Sold Not Yet Purchased At Fair Value
FinancialInstrumentsSoldNotYetPurchasedAtFairValue
0
CY2022Q4 us-gaap Financial Instruments Sold Not Yet Purchased At Fair Value
FinancialInstrumentsSoldNotYetPurchasedAtFairValue
0
CY2023Q3 us-gaap Fee Income
FeeIncome
0
us-gaap Fee Income
FeeIncome
0
CY2022Q3 us-gaap Fee Income
FeeIncome
0
us-gaap Fee Income
FeeIncome
0
CY2023Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
47602572
CY2023Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
47602572
CY2022Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
53293715
CY2022Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
53293715
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2023Q3 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Asset
FairValueDisclosureOffbalanceSheetRisksAmountAsset
0
CY2022Q3 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Asset
FairValueDisclosureOffbalanceSheetRisksAmountAsset
0
us-gaap Revenue Recognition Interest
RevenueRecognitionInterest
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Recognition </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Corporate actions (including cash dividends from common stock and equity tranches of asset-backed securities) are recorded on the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ex-dividend</div> date, net of applicable withholding taxes, except for certain foreign corporate actions, which are recorded as soon after the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ex-dividend</div> date as such information becomes available. Interest income is recorded on the accrual basis. The Company does not accrue as a receivable for interest or dividends on loans, asset-backed securities and other securities if there is a reason to doubt the Company’s ability to collect such income. For loans with contractual PIK <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(payment-in-kind)</div></div> interest income, which represents contractual interest accrued and added to the loan balance that generally becomes due at maturity, we will not accrue PIK interest if we believe that the PIK interest is no longer collectible. Loan origination fees, original issue discount and market discount are capitalized and such amounts are amortized as interest income over the respective term of the loan or security. Upon the prepayment of a loan or security, any unamortized loan origination fees and original issue discount are recorded as interest income. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Accretion of discounts and amortization of premiums on taxable bonds, loans and asset-backed securities are computed to the call or maturity date, whichever is shorter, using the effective yield method. Withholding taxes on foreign dividends have been provided for in accordance with the Company’s understanding of the applicable country’s tax rules and rates. </div>
cik0001588272 Offering Costs As A Percentage Of Total Proceeds Raised
OfferingCostsAsAPercentageOfTotalProceedsRaised
0.01
cik0001588272 Offering Costs As A Percentage Of Total Proceeds Raised
OfferingCostsAsAPercentageOfTotalProceedsRaised
0.01
cik0001588272 Stock Issuance Costs
StockIssuanceCosts
0
cik0001588272 Stock Issuance Costs
StockIssuanceCosts
0
cik0001588272 Organization Costs And Offering Costs Are Limited To Percentage Of Total Gross Proceeds Raised In The Offering
OrganizationCostsAndOfferingCostsAreLimitedToPercentageOfTotalGrossProceedsRaisedInTheOffering
0.01
cik0001588272 Adviser Forfeited The Right To Reimbursement Of The Remaining Amount Of Costs Subsequent To Termination Of The Offering
AdviserForfeitedTheRightToReimbursementOfTheRemainingAmountOfCostsSubsequentToTerminationOfTheOffering
4305091
CY2023Q3 cik0001588272 Annual Retainer Amount Payable In Quarterly Installments To Related Party Oversees All Of The Portfolios In The Fund Complex
AnnualRetainerAmountPayableInQuarterlyInstallmentsToRelatedPartyOverseesAllOfThePortfoliosInTheFundComplex
150000
CY2023Q3 cik0001588272 Annual Retainer Amount Payable In Quarterly Installments To Related Party Who Does Not Oversees All Portfolios On Prorated Basis Of Who Oversees All Portfolios
AnnualRetainerAmountPayableInQuarterlyInstallmentsToRelatedPartyWhoDoesNotOverseesAllPortfoliosOnProratedBasisOfWhoOverseesAllPortfolios
150000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
704461
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2652623
us-gaap Net Income Loss
NetIncomeLoss
-388293
us-gaap Net Income Loss
NetIncomeLoss
-4435887
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9471078
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9471078
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9882443
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9882443
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9580222
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9580222
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9940512
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9940512
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2022Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.09
CY2023Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.09
CY2023Q3 cik0001588272 Additional Payment Amount Eligible To Receive By Related Party Payable In Quarterly Installments
AdditionalPaymentAmountEligibleToReceiveByRelatedPartyPayableInQuarterlyInstallments
10000
CY2023Q3 cik0001588272 Directors Fee Expense
DirectorsFeeExpense
-1471
cik0001588272 Directors Fee Expense
DirectorsFeeExpense
9231
CY2022Q3 cik0001588272 Directors Fee Expense
DirectorsFeeExpense
4421
cik0001588272 Directors Fee Expense
DirectorsFeeExpense
12134
CY2023Q3 cik0001588272 Director Fee Expense Payable Amount
DirectorFeeExpensePayableAmount
0
CY2023Q3 cik0001588272 Expense Reimbursements Amount That Are Eligible For Recoupment By The Adviser Expired
ExpenseReimbursementsAmountThatAreEligibleForRecoupmentByTheAdviserExpired
94039
cik0001588272 Expense Reimbursements Amount That Are Eligible For Recoupment By The Adviser Expired
ExpenseReimbursementsAmountThatAreEligibleForRecoupmentByTheAdviserExpired
247947
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
47602572
CY2023Q3 cik0001588272 Investment Owned Percentage Of Total Assets
InvestmentOwnedPercentageOfTotalAssets
1
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
53293715
CY2022Q4 cik0001588272 Investment Owned Percentage Of Total Assets
InvestmentOwnedPercentageOfTotalAssets
1
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
46250353
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
47602572
CY2023Q3 cik0001588272 Investment Owned Percentage Of Total Assets
InvestmentOwnedPercentageOfTotalAssets
1
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
54011971
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
53293715
CY2022Q4 cik0001588272 Investment Owned Percentage Of Total Assets
InvestmentOwnedPercentageOfTotalAssets
1
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
47602572
CY2023Q3 cik0001588272 Investment Owned Percentage Of Total Assets
InvestmentOwnedPercentageOfTotalAssets
1
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
53293715
CY2022Q4 cik0001588272 Investment Owned Percentage Of Total Assets
InvestmentOwnedPercentageOfTotalAssets
1
cik0001588272 Base Management Fee Calculated Annual Rate Of Percentage Of Average Value Of Gross Assets
BaseManagementFeeCalculatedAnnualRateOfPercentageOfAverageValueOfGrossAssets
0.02
CY2023Q3 cik0001588272 Investment Advisory Fee
InvestmentAdvisoryFee
207269
cik0001588272 Investment Advisory Fee
InvestmentAdvisoryFee
705652
CY2022Q3 cik0001588272 Investment Advisory Fee
InvestmentAdvisoryFee
254995
cik0001588272 Investment Advisory Fee
InvestmentAdvisoryFee
836626
cik0001588272 Maximum Recoupment Of Other Expenses Exceeds The Annual Rate Percentage Of Average Gross Assets
MaximumRecoupmentOfOtherExpensesExceedsTheAnnualRatePercentageOfAverageGrossAssets
0.034
cik0001588272 Subordinated Incentive Fee On Income Is Determined And Payable Quarterly In Arrears Equals Percentage Of Pre Incentive Fee Net Investment Income
SubordinatedIncentiveFeeOnIncomeIsDeterminedAndPayableQuarterlyInArrearsEqualsPercentageOfPreIncentiveFeeNetInvestmentIncome
0.20
cik0001588272 Hurdle Rate Expressed As Rate Of Return On Net Assets Equal To Percentage Per Quarter
HurdleRateExpressedAsRateOfReturnOnNetAssetsEqualToPercentagePerQuarter
0.01875
cik0001588272 Hurdle Rate
HurdleRate
0.01875
CY2023Q3 cik0001588272 Pre Incentive Fee Net Investment Income For Quarter Equals Percentage Of Net Assets At The End Of Quarter
PreIncentiveFeeNetInvestmentIncomeForQuarterEqualsPercentageOfNetAssetsAtTheEndOfQuarter
0.0234375
CY2023Q3 cik0001588272 Catch Up Fee Receive By The Adviser Percentage Of The Pre Incentive Fee Net Investment Income From The Quarter
CatchUpFeeReceiveByTheAdviserPercentageOfThePreIncentiveFeeNetInvestmentIncomeFromTheQuarter
0.20
CY2023Q3 cik0001588272 Percentage Of Incentive Fee Capital Gains Is Determined And Payable In Arrears As At End Of Each Calender Year
PercentageOfIncentiveFeeCapitalGainsIsDeterminedAndPayableInArrearsAsAtEndOfEachCalenderYear
0.20
CY2023Q3 cik0001588272 Incentive Fee Expense On Capital Gains
IncentiveFeeExpenseOnCapitalGains
0
cik0001588272 Incentive Fee Expense On Capital Gains
IncentiveFeeExpenseOnCapitalGains
0
CY2022Q3 cik0001588272 Incentive Fee Expense On Capital Gains
IncentiveFeeExpenseOnCapitalGains
0
cik0001588272 Incentive Fee Expense On Capital Gains
IncentiveFeeExpenseOnCapitalGains
0
CY2023Q3 cik0001588272 Aggregate Accrued Incentive Fees On Capital Gains
AggregateAccruedIncentiveFeesOnCapitalGains
0
cik0001588272 Payment Of Incentive Fees With Respect To Realized Gains To The Adviser
PaymentOfIncentiveFeesWithRespectToRealizedGainsToTheAdviser
0
cik0001588272 Minimum Reimbursement Amount As A Percentage Of Average Gross Assets
MinimumReimbursementAmountAsAPercentageOfAverageGrossAssets
0.004
cik0001588272 Annual Rate Percentage Of Average Gross Assets
AnnualRatePercentageOfAverageGrossAssets
0.034
cik0001588272 Organization Costs And Offering Costs Are Limited To Percentage Of Total Gross Proceeds Raised In The Offering
OrganizationCostsAndOfferingCostsAreLimitedToPercentageOfTotalGrossProceedsRaisedInTheOffering
0.01
CY2023Q3 cik0001588272 Cumulative Aggregate Amount Of Organization And Offering Costs
CumulativeAggregateAmountOfOrganizationAndOfferingCosts
5327574
CY2023Q3 cik0001588272 Percentage Of Distribution To Shareholders Investment Company Taxable Income
PercentageOfDistributionToShareholdersInvestmentCompanyTaxableIncome
0.90
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.98
us-gaap Effective Income Tax Rate Reconciliation Disposition Of Assets
EffectiveIncomeTaxRateReconciliationDispositionOfAssets
0.982
cik0001588272 Share Repurchase Program
ShareRepurchaseProgram
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 6 — Share Repurchase Program </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On a quarterly basis, the Company intends to offer to repurchase shares of common stock on such terms as may be determined by the Board in its complete and absolute discretion unless, in the judgment of directors who are not “interested persons” of the Company (as defined in the 1940 Act), such repurchases would not be in the best interests of the Company’s stockholders or would violate applicable law. The Company will conduct such repurchase offers in accordance with the requirements of Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">13e-4</div> of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the 1940 Act. Any offer to repurchase shares of common stock will be conducted solely through tender offer materials furnished to each stockholder. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company currently intends to limit the number of shares of common stock to be repurchased during any calendar year to the number of shares of common stock it can repurchase with the proceeds it receives from the sale of shares of common stock under its distribution reinvestment plan. At the discretion of the Board, the Company may also use cash on hand, cash available from borrowings and cash from liquidation of securities investments as of the end of the applicable period to repurchase shares of common stock. In addition, the Company will limit the number of shares of common stock to be repurchased in any calendar year to 10.0% of the weighted average number of shares of common stock outstanding in the prior calendar year, or 2.5% in each quarter, though the actual number of shares of common stock that the Company offers to repurchase may be less in light of the limitations noted above. The Company intends to offer to repurchase such shares of common stock at a price (i) not less than the net asset value per share (the “NAV Per Share”) of the Company’s common stock next calculated following the Expiration Date, and (ii) not more than 2.5% greater than the NAV Per Share as of such date. The Board may amend, suspend or terminate the share repurchase program at any time, upon 30 days’ notice. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company conducted its quarterly tender offer for the third quarter of 2023 from <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">August</div> 23, 2023, until expiration of September 25, 2023, at 4:00 p.m. New York City time, during which the Company offered to purchase for cash up to 2.5% of its outstanding shares of common stock. During the third quarter tender offer, 118,580 shares of the Company were tendered for repurchase, constituting approximately 1.20% of the Company’s outstanding shares. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For the nine months ended September 30, 2023, the Company repurchased 0 shares as part of its death and disability repurchase program. </div>
CY2023Q3 cik0001588272 Minimum Limit Of Shares To Be Repurchased Percent
MinimumLimitOfSharesToBeRepurchasedPercent
0.10
CY2022Q4 cik0001588272 Minimum Limit Of Shares To Be Repurchased Percent
MinimumLimitOfSharesToBeRepurchasedPercent
0.025
CY2023Q3 cik0001588272 Percentage Of Shares To Be Issued Under Ceiling Limit Of Net Asset Value Per Share
PercentageOfSharesToBeIssuedUnderCeilingLimitOfNetAssetValuePerShare
0.025
CY2023Q3 cik0001588272 Minimum Notice Period Of Shares To Be Suspend Or Terminate
MinimumNoticePeriodOfSharesToBeSuspendOrTerminate
0.30
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
956291
CY2022Q4 cik0001588272 Affiliated Investment Owned At Fair Value
AffiliatedInvestmentOwnedAtFairValue
10273001
us-gaap Investments In And Advances To Affiliates At Fair Value Period Increase Decrease
InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease
0
us-gaap Investments In And Advances To Affiliates At Fair Value Gross Additions
InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions
7911399
us-gaap Investments In And Advances To Affiliates At Fair Value Gross Reductions
InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions
7448085
cik0001588272 Investments In And Advances To Affiliates At Fair Value Realized Gains Losses
InvestmentsInAndAdvancesToAffiliatesAtFairValueRealizedGainsLosses
0
cik0001588272 Investments In And Advances To Affiliates At Fair Value Changein Unrealized Appreciation Depreciation
InvestmentsInAndAdvancesToAffiliatesAtFairValueChangeinUnrealizedAppreciationDepreciation
249159
CY2023Q3 cik0001588272 Affiliated Investment Owned At Fair Value
AffiliatedInvestmentOwnedAtFairValue
10985474
CY2023Q3 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
526928
us-gaap Dividend Income Operating
DividendIncomeOperating
830079
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
5.55
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
6.32
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.16
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.17
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.2
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.62
us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-0.04
us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-0.45
cik0001588272 Investment Companyfrom Net Investment Income Per Share
InvestmentCompanyfromNetInvestmentIncomePerShare
-0.27
cik0001588272 Investment Companyfrom Net Investment Income Per Share
InvestmentCompanyfromNetInvestmentIncomePerShare
-0.27
cik0001588272 Distributions Declared To Common Shareholders
DistributionsDeclaredToCommonShareholders
0.27
cik0001588272 Distributions Declared To Common Shareholders
DistributionsDeclaredToCommonShareholders
0.27
cik0001588272 Investment Companyissuance Of Common Stock Per Share
InvestmentCompanyissuanceOfCommonStockPerShare
0
cik0001588272 Investment Companyissuance Of Common Stock Per Share
InvestmentCompanyissuanceOfCommonStockPerShare
0
cik0001588272 Investment Companyshares Tendered Per Share
InvestmentCompanysharesTenderedPerShare
0
cik0001588272 Investment Companyshares Tendered Per Share
InvestmentCompanysharesTenderedPerShare
0
CY2023Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
5.24
CY2022Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
5.6
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0068
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0733
CY2023Q3 us-gaap Assets Net
AssetsNet
49048000
CY2022Q3 us-gaap Assets Net
AssetsNet
54423000
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9356005
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9717788
us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0393
us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0376
us-gaap Investment Company Expense Ratio Voluntary Fee Waiver
InvestmentCompanyExpenseRatioVoluntaryFeeWaiver
0.0073
us-gaap Investment Company Expense Ratio Voluntary Fee Waiver
InvestmentCompanyExpenseRatioVoluntaryFeeWaiver
0.0062
us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.032
us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0314
us-gaap Investment Company Investment Income Loss Ratio Before Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation
0.0332
us-gaap Investment Company Investment Income Loss Ratio Before Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation
0.0304
us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
0.0405
us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
0.0367
cik0001588272 Investment Companyportfolio Turnover Rate
InvestmentCompanyportfolioTurnoverRate
0.05
cik0001588272 Investment Companyportfolio Turnover Rate
InvestmentCompanyportfolioTurnoverRate
0.14
cik0001588272 Investment Companyasset Coverage Ratio
InvestmentCompanyassetCoverageRatio
0
cik0001588272 Investment Companyasset Coverage Ratio
InvestmentCompanyassetCoverageRatio
0
us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0
us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0

Files In Submission

Name View Source Status
0001193125-23-276929-index-headers.html Edgar Link pending
0001193125-23-276929-index.html Edgar Link pending
0001193125-23-276929.txt Edgar Link pending
0001193125-23-276929-xbrl.zip Edgar Link pending
cik0001588272-20230930.xsd Edgar Link pending
d548910d10q.htm Edgar Link pending
d548910dex311.htm Edgar Link pending
d548910dex312.htm Edgar Link pending
d548910dex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
d548910d10q_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cik0001588272-20230930_pre.xml Edgar Link unprocessable
cik0001588272-20230930_lab.xml Edgar Link unprocessable
cik0001588272-20230930_def.xml Edgar Link unprocessable
cik0001588272-20230930_cal.xml Edgar Link unprocessable